Clinical trial

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

NCT02595372

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-12

PhasePHASE2

Study timeline

Study start (actual)2015-11-12Date precision: day

Registry last updated2021-12-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancer of the Breastunresolved

Interventions

OmeprazoleDRUG · verified · RxNorm: omeprazole

Sponsors & collaborators

Kathy Millerlead sponsor

Mapped research locations

IndianapolisIndiana, United States3 Washington D.C.District of Columbia, United States2 BaltimoreMaryland, United States1 ColumbusOhio, United States1 Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02595372 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.